Cymabay Therapeutics
Mandy Ayi, MHA, PACS, is an experienced healthcare professional specializing in patient access and support services. Currently serving as the Director of Patient Services at CymaBay Therapeutics, Mandy previously held the position of Director of Patient Access at AVEO Oncology, where a comprehensive patient support program for FOTIVDA was successfully launched. Prior roles include Senior Manager of Patient Access at Karyopharm Therapeutics, Supervisor of Patient Access at Alkermes, and various positions at Celgene Pharma, where extensive training and operational improvements were implemented to enhance patient care and streamline processes. Mandy holds a Bachelor of Science degree from Rutgers University–New Brunswick and a Master's in Healthcare Administration from Seton Hall University.
This person is not in any teams
This person is not in any offices
Cymabay Therapeutics
1 followers
CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases.